title: The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.
abstract: A marked increase in leukemia risks was the first and most striking late effect of radiation exposure seen among the Hiroshima and Nagasaki atomic bomb survivors. This article presents analyses of radiation effects on leukemia, lymphoma and multiple myeloma incidence in the Life Span Study cohort of atomic bomb survivors updated 14 years since the last comprehensive report on these malignancies. These analyses make use of tumor- and leukemia-registry based incidence data on 113,011 cohort members with 3.6 million person-years of follow-up from late 1950 through the end of 2001. In addition to a detailed analysis of the excess risk for all leukemias other than chronic lymphocytic leukemia or adult T-cell leukemia (neither of which appear to be radiation-related), we present results for the major hematopoietic malignancy types: acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, adult T-cell leukemia, Hodgkin and non-Hodgkin lymphoma and multiple myeloma. Poisson regression methods were used to characterize the shape of the radiation dose-response relationship and, to the extent the data allowed, to investigate variation in the excess risks with gender, attained age, exposure age and time since exposure. In contrast to the previous report that focused on describing excess absolute rates, we considered both excess absolute rate (EAR) and excess relative risk (ERR) models and found that ERR models can often provide equivalent and sometimes more parsimonious descriptions of the excess risk than EAR models. The leukemia results indicated that there was a nonlinear dose response for leukemias other than chronic lymphocytic leukemia or adult T-cell leukemia, which varied markedly with time and age at exposure, with much of the evidence for this nonlinearity arising from the acute myeloid leukemia risks. Although the leukemia excess risks generally declined with attained age or time since exposure, there was evidence that the radiation-associated excess leukemia risks, especially for acute myeloid leukemia, had persisted throughout the follow-up period out to 55 years after the bombings. As in earlier analyses, there was a weak suggestion of a radiation dose response for non-Hodgkin lymphoma among men, with no indication of such an effect among women. There was no evidence of radiation-associated excess risks for either Hodgkin lymphoma or multiple myeloma.
authors: Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan.
authors: Wan-Ling
authors: WL
authors: Hsu
authors: Dale L
authors: DL
authors: Preston
authors: Midori
authors: M
authors: Soda
authors: Hiromi
authors: H
authors: Sugiyama
authors: Sachiyo
authors: S
authors: Funamoto
authors: Kazunori
authors: K
authors: Kodama
authors: Akiro
authors: A
authors: Kimura
authors: Nanao
authors: N
authors: Kamada
authors: Hiroo
authors: H
authors: Dohy
authors: Masao
authors: M
authors: Tomonaga
authors: Masako
authors: M
authors: Iwanaga
authors: Yasushi
authors: Y
authors: Miyazaki
authors: Harry M
authors: HM
authors: Cullings
authors: Akihiko
authors: A
authors: Suyama
authors: Kotaro
authors: K
authors: Ozasa
authors: Roy E
authors: RE
authors: Shore
authors: Kiyohiko
authors: K
authors: Mabuchi
mesh_terms: D015331:Cohort Studies; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D007938:Leukemia / Q000453:epidemiology*; D008223:Lymphoma / Q000453:epidemiology*; D009101:Multiple Myeloma / Q000453:epidemiology*; D009689:Nuclear Warfare; D012042:Registries; D017741:Survivors
references: Radiat Res. 2004 Oct;162(4):377-89
references: 15447045
references: Radiat Res. 2008 Dec;170(6):721-35
references: 19138033
references: Radiat Res. 2009 Sep;172(3):368-82
references: 19708786
references: Radiat Res. 2006 Jul;166(1 Pt 2):219-54
references: 16808610
references: Am J Epidemiol. 2009 Apr 15;169(8):969-76
references: 19270049
references: Radiat Res. 1990 Sep;123(3):275-84
references: 2217725
references: Radiat Environ Biophys. 2010 May;49(2):195-201
references: 20012750
references: Radiat Res. 2008 Nov;170(5):661-5
references: 18959468
references: Environ Health Perspect. 2005 Jan;113(1):1-5
references: 15626639
references: Br J Haematol. 1976 Aug;33(4):451-8
references: 188440
references: Radiat Res. 2007 Jul;168(1):1-64
references: 17722996
references: Radiat Res. 2003 Jun;159(6):787-98
references: 12751962
references: Radiat Res. 2012 Mar;177(3):229-43
references: 22171960
references: J Radiat Res. 1978 Sep;19(3):262-82
references: 739446
references: Br J Haematol. 2007 Dec;139(5):672-86
references: 18021081
references: Jpn J Clin Oncol. 2004 Oct;34(10):634-7
references: 15591464
references: Br J Cancer. 2009 Jan 13;100(1):206-12
references: 19127272
references: N Engl J Med. 1955 Jul 21;253(3):88-90
references: 14394332
references: Int J Cancer. 1990 Feb 15;45(2):237-43
references: 2303290
references: Radiat Res. 1996 Jul;146(1):1-27
references: 8677290
references: Radiat Res. 1994 Feb;137(2 Suppl):S1-16
references: 8127951
references: Radiat Res. 2008 Dec;170(6):711-20
references: 19138038
references: Radiat Res. 1971 Jan;45(1):216-33
references: 5275936
references: J Clin Oncol. 2011 Feb 1;29(4):428-34
references: 21149671
references: Radiat Res. 1993 May;134(2):134-42
references: 8488248
references: Am J Epidemiol. 2001 Feb 15;153(4):309-18
references: 11207146
references: Science. 1958 Mar 28;127(3300):699-700
references: 13529036
references: Radiat Res. 2005 Mar;163(3):258-65
references: 15733032
references: Jpn J Clin Oncol. 1988 Jun;18(2):91-6
references: 2898029
references: Radiat Res. 1994 Feb;137(2 Suppl):S68-97
references: 8127953
references: Environ Health Perspect. 2006 Jun;114(6):818-22
references: 16759978
references: Science. 1957 May 17;125(3255):965-72
references: 13421705
references: Am J Med. 1952 Sep;13(3):311-21
references: 12985588